-
-
-
-
-
-
-
Leading Independent Proxy Advisory Firm ISS Recommends Akebia Shareholders Vote “FOR” Proposed Merger with Keryx
-
-
-
-
-
-
-
Keryx Biopharmaceuticals Announces Filing of Definitive Joint Proxy Statement in Connection with Pending Merger with Akebia Therapeutics
-
-
-
-
-
-
-
Akebia Therapeutics (AKBA) and Keryx Biopharmaceuticals (KERX) to Merge
-
-
-
-
-
-
-
Keryx Biopharma (KERX) Adds Two Board Members
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 9/3: (KBIO) (PSEM) (MM) Higher; (JOY) (WPCS) (KERX) Lower
-
-
-
-
-
-
-
Keryx Biopharmaceuticals, Inc. Announces $100 Million Proposed Public Offering of Common Stock
-
-
-
-
-
-
-
Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results
-
1,154,894 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

